The team set up conditions so that the only mutant genes to thrive are the ones encoding proteins capable of accomplishing the desired function within the cells including activating a particular receptor or switching on specific genes
According to the pioneers of the human-on-a-chip in vitro system, they announced the use of its unique multi-organ model to successfully measure the concentration and metabolism of two known cardiotoxic small molecules over time, to accurately describe the drug behavior and toxic effects in vivo. Furthermore, the findings support the potential of body-on-a-chip systems to transform the drug discovery process.
The accumulation of alpha-synuclein proteins in the brain is the culprit behind the neurogenerative disorder in Parkinson's disease. Current knowledge cannot explain wholly how alpha-synuclein works, but with its impact in neurogenerative diseases, scientists aim to broaden the knowledge scope on Parkinson's disease and find new treatment methods.
Attaching a Velcro-like molecule may prevent immune proteins from leaking out after injection. Cytokines, small proteins released by immune cells to communicate with each other, have for some time been investigated as a potential cancer treatment.
Collaborators from the University of Cambridge and the Wellcome Sanger Institute suggests that some MRSA infections could be solved using widely-used antibiotics.
The study suggests that the blows to the head caused brain injury and by oxygen deprivation are likely ongoing health issues for many domestic violence survivors